selected publications
- Endothelial cell sphingosine 1-phosphate receptor 1 restrains VE-cadherin cleavage and attenuates experimental inflammatory arthritis. JCI insight. 2024 Academic Article GET IT
-
Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases.
Nature reviews. Rheumatology.
2022
Review
GET IT
Times cited: 3 -
Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.
Arthritis & rheumatology (Hoboken, N.J.).
2018
Academic Article
GET IT
Times cited: 75 -
An engineered S1P chaperone attenuates hypertension and ischemic injury.
Science signaling.
2017
Academic Article
GET IT
Times cited: 84 -
Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1.
Proceedings of the National Academy of Sciences of the United States of America.
2017
Academic Article
GET IT
Times cited: 156 -
Increased Smad2/3 phosphorylation in circulating leukocytes and platelet-leukocyte aggregates in a mouse model of aortic valve stenosis: Evidence of systemic activation of platelet-derived TGF-β1 and correlation with cardiac dysfunction.
Blood cells, molecules & diseases.
2016
Academic Article
GET IT
Times cited: 7 -
In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1.
Blood.
2008
Academic Article
GET IT
Times cited: 134 -
The neutrophil: function and regulation in innate and humoral immunity.
Clinical immunology (Orlando, Fla.).
2001
Review
GET IT
Times cited: 220